These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8849650)

  • 1. Investigation of nosocomial respiratory infection due to Pseudomonas cepacia by arbitrarily primed polymerase chain reaction.
    Miyawaki H; Fujita J; Takigawa K; Negayama K; Yamagishi Y; Yamaji Y; Ouchi K; Nakazawa T; Kawanishi K; Takahara J
    Diagn Microbiol Infect Dis; 1995 Nov; 23(3):77-83. PubMed ID: 8849650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients.
    Bingen EH; Weber M; Derelle J; Brahimi N; Lambert-Zechovsky NY; Vidailhet M; Navarro J; Elion J
    J Clin Microbiol; 1993 Oct; 31(10):2589-93. PubMed ID: 7504684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates.
    Liu PY; Shi ZY; Lau YJ; Hu BS; Shyr JM; Tsai WS; Lin YH; Tseng CY
    J Clin Microbiol; 1995 Dec; 33(12):3304-7. PubMed ID: 8586722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks.
    Okazaki M; Watanabe T; Morita K; Higurashi Y; Araki K; Shukuya N; Baba S; Watanabe N; Egami T; Furuya N; Kanamori M; Shimazaki S; Uchimura H
    J Clin Microbiol; 1999 Dec; 37(12):3809-14. PubMed ID: 10565889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arbitrarily primed PCR and sequencing of 16S rDNA for epidemiological typing and species identification of Burkholderia cepacia isolates from Swedish patients with cystic fibrosis reveal genetic heterogeneity.
    Karpati F; Giedraitis V; Thore M; Lindman R; Monstein HJ; Hjelte L; Jonasson J
    APMIS; 2001 May; 109(5):389-400. PubMed ID: 11478687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III.
    Coenye T; Spilker T; Martin A; LiPuma JJ
    J Clin Microbiol; 2002 Sep; 40(9):3300-7. PubMed ID: 12202570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Sau-PCR for molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia which occurred in a local hospital in Guangzhou, China.
    Yan H; Shi L; Alam MJ; Li L; Yang L; Yamasaki S
    Microbiol Immunol; 2008 May; 52(5):283-6. PubMed ID: 18557899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of strains of Burkholderia (Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing.
    Ouchi K; Abe M; Karita M; Oguri T; Igari J; Nakazawa T
    J Clin Microbiol; 1995 Sep; 33(9):2353-7. PubMed ID: 7494027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia in cystic fibrosis patients of Masih Daneshvary Hospital, Iran.
    Dallal MM; Telefian CF; Hajia M; Kalantar E; Dehkharghani AR; Forushani AR; Khanbabaei Q; Mobarhan M; Farzami MR
    J Prev Med Hyg; 2014 Mar; 55(1):27-30. PubMed ID: 25916029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained endemicity of Burkholderia cepacia complex in a pediatric institution, associated with contaminated ultrasound gel.
    Jacobson M; Wray R; Kovach D; Henry D; Speert D; Matlow A
    Infect Control Hosp Epidemiol; 2006 Apr; 27(4):362-6. PubMed ID: 16622813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak.
    Pegues CF; Pegues DA; Ford DS; Hibberd PL; Carson LA; Raine CM; Hooper DC
    Epidemiol Infect; 1996 Jun; 116(3):309-17. PubMed ID: 8666075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital.
    Siddiqui AH; Mulligan ME; Mahenthiralingam E; Hebden J; Brewrink J; Qaiyumi S; Johnson JA; LiPuma JJ
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):419-22. PubMed ID: 11583209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological investigation of nosocomial Acinetobacter infections using arbitrarily primed PCR & pulse field gel electrophoresis.
    Prashanth K; Badrinath S
    Indian J Med Res; 2005 Nov; 122(5):408-18. PubMed ID: 16456255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.
    Campana S; Taccetti G; Ravenni N; Favari F; Cariani L; Sciacca A; Savoia D; Collura A; Fiscarelli E; De Intinis G; Busetti M; Cipolloni A; d'Aprile A; Provenzano E; Collebrusco I; Frontini P; Stassi G; Trancassini M; Tovagliari D; Lavitola A; Doherty CJ; Coenye T; Govan JR; Vandamme P
    J Clin Microbiol; 2005 Oct; 43(10):5136-42. PubMed ID: 16207975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of arbitrarily primed PCR for typing of Staphylococcus aureus strains.
    van Belkum A; Kluytmans J; van Leeuwen W; Bax R; Quint W; Peters E; Fluit A; Vandenbroucke-Grauls C; van den Brule A; Koeleman H
    J Clin Microbiol; 1995 Jun; 33(6):1537-47. PubMed ID: 7650182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy.
    Hamill RJ; Houston ED; Georghiou PR; Wright CE; Koza MA; Cadle RM; Goepfert PA; Lewis DA; Zenon GJ; Clarridge JE
    Ann Intern Med; 1995 May; 122(10):762-6. PubMed ID: 7536401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field inversion gel electrophoresis on Pseudomonas cepacia strains isolated from cystic fibrosis patients.
    Amalfitano G; Tonolli E; Favari F; Perazzoli C; Cazzola G; Mastella G; Piacentini I
    Eur J Epidemiol; 1996 Apr; 12(2):149-53. PubMed ID: 8817193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland.
    Pitt TL; Kaufmann ME; Patel PS; Benge LC; Gaskin S; Livermore DM
    J Med Microbiol; 1996 Mar; 44(3):203-10. PubMed ID: 8636938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA fingerprinting by arbitrarily primed polymerase chain reaction (AP-PCR) for methicillin-resistant Staphylococcus aureus].
    Hojo S; Fujita J; Negayama K; Ohnishi T; Xu G; Yamaji Y; Okada H; Takahara J
    Kansenshogaku Zasshi; 1995 May; 69(5):506-10. PubMed ID: 7602182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and molecular characterization of a clone of Burkholderia cenocepacia responsible for nosocomial pulmonary tract infections in a French intensive care unit.
    Graindorge A; Menard A; Neto M; Bouvet C; Miollan R; Gaillard S; de Montclos H; Laurent F; Cournoyer B
    Diagn Microbiol Infect Dis; 2010 Jan; 66(1):29-40. PubMed ID: 19716254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.